AlphaCentric Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
14,451
+206
+1% +$20.4K 1.39% 8
2026
Q1
$1.34M Buy
14,245
+774
+6% +$77.2K 1.34% 10
2025
Q4
$1.33M Buy
+13,471
New +$1.3M 1.33% 12
2021
Q4
$1.47M Buy
20,000
+4,750
+31% +$320K 0.43% 13
2021
Q3
$1.05M Buy
15,250
+11,250
+281% +$855K 0.27% 25
2021
Q2
$337K Sell
4,000
-2,250
-36% -$188K 0.09% 82
2021
Q1
$508K Buy
6,250
+3,750
+150% +$320K 0.17% 44
2020
Q4
$217K Buy
+2,500
New +$216K 0.09% 62

Other funds holding INCY

AlphaCentric Advisors's INCY Position: Q2 2026 in Review

AlphaCentric Advisors increased its Incyte (INCY) stake by 1.4% in Q2 2026, buying an estimated $20.4K and bringing the position to 14,451 shares worth $1.64M. The position accounts for 1.39% of the portfolio, ranked #8.

AlphaCentric Advisors first reported a position in INCY in Q4 2020 and has held it in 8 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • AlphaCentric Advisors held 14,451 shares of Incyte worth $1.64M as of Q2 2026.
  • AlphaCentric Advisors bought 206 Incyte shares in Q2 2026, an estimated $20.4K.
  • Incyte made up 1.39% of AlphaCentric Advisors's portfolio in Q2 2026, its #8 holding.
  • AlphaCentric Advisors first reported a position in Incyte in Q4 2020 and has held it in 8 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.